BR100 Increased By (0.39%)
BR30 Increased By (0.47%)
KSE100 Increased By (0.6%)
KSE30 Increased By (0.7%)
AGHA 6.55 Increased By ▲ 0.23 (3.64%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.43 Decreased By ▼ -0.02 (-0.03%)
BOP 31.38 Increased By ▲ 0.15 (0.48%)
CNERGY 11.79 Increased By ▲ 0.20 (1.73%)
CSIL 5.95 Increased By ▲ 0.23 (4.02%)
FCCL 61.12 Decreased By ▼ -0.42 (-0.68%)
FFL 14.88 Decreased By ▼ -0.14 (-0.93%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.29 Increased By ▲ 0.03 (0.48%)
KOSM 6.00 Increased By ▲ 0.44 (7.91%)
LOTCHEM 24.85 Increased By ▲ 0.17 (0.69%)
MLCF 104.13 Increased By ▲ 0.05 (0.05%)
NBP 174.66 Decreased By ▼ -0.62 (-0.35%)
NCPL 52.83 Increased By ▲ 0.06 (0.11%)
NPL 54.48 Increased By ▲ 0.36 (0.67%)
OGDC 315.35 Increased By ▲ 1.96 (0.63%)
PACE 9.41 Increased By ▲ 0.21 (2.28%)
PAEL 35.62 Decreased By ▼ -0.18 (-0.5%)
PIBTL 13.71 Increased By ▲ 0.24 (1.78%)
PPL 223.38 Increased By ▲ 1.57 (0.71%)
PRL 80.79 Increased By ▲ 1.71 (2.16%)
PTC 47.15 Increased By ▲ 0.30 (0.64%)
SSGC 24.15 Increased By ▲ 0.28 (1.17%)
TBL 9.25 Decreased By ▼ -0.06 (-0.64%)
TELE 7.53 Increased By ▲ 0.14 (1.89%)
TPL 24.89 Decreased By ▼ -0.22 (-0.88%)
TPLP 12.88 Increased By ▲ 0.37 (2.96%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 53.75 Increased By ▲ 0.31 (0.58%)
World

Canada's Trudeau says Pfizer vaccine results 'promising'

  • Canada signed a deal with US giant Pfizer and its German partner BioNTech in August for a minimum of 20 million doses of their vaccine.
Published Updated
By

OTTAWA: Prime Minister Justin Trudeau said Monday he was encouraged by Pfizer and BioNTech's announcement that their Covid-19 vaccine in trials proved 90 percent effective, adding it could be available in Canada in early 2021.

The two pharmaceutical companies said the vaccine they have jointly developed had during Phase 3 trials provided protection to nearly all patients seven days after the second of two vaccine doses.

At a news conference, Trudeau called the results "promising." "We see the light at the end of the tunnel," he said.

The prime minister said he expects the vaccine to be distributed to Canadians "most likely in the first three months of 2021."

"But," he added, "there is a lot of uncertainty involved in these processes."

Canada signed a deal with US giant Pfizer and its German partner BioNTech in August for a minimum of 20 million doses of their vaccine.

It was at the time the most advanced vaccine candidate in development among several of which Canada secured access.

Other agreements were signed with AstraZeneca, Sanofi and GSK, Novavax, Johnson & Johnson, Medicago and Moderna for a total of more than 300 million doses for its population of 38 million.

Trudeau noted that the Pfizer-BioNTech vaccine poses some "logistical distribution" challenges, including that it must be stored at very cold temperatures and therefore getting it to Canadians will be "more complex and slightly more limiting."

"We are already working on those necessary logistical supports," he said.

Trudeau also said that testing of several other vaccine candidates was "progressing well" and some of those could be rolled out in early 2021 too.

Until then, he encouraged Canadians to continue to take precautions to limit the spread of the Covid-19 illness, including social distancing and wearing masks.

As of Monday, Canada has reported more than 260,000 Covid-19 infections, including 10,500 deaths.

"To be very clear: If you catch Covid in the coming days and weeks, a vaccine won't help you or your family," Trudeau concluded.

Comments

Comments are closed for this article.